Pipeline Update: Xiaomi backed Hesai Group among new filings to trickle in
NEW FILINGS (also updated prospectuses) Company: Mineralys Therapeutics, Inc. Symbol: MLYS (Nasdaq) Description: They are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Shares: TBD Price Range: TBD Trade Date: TBD Underwriters: BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse, Wells Fargo Link to Prospectus:[…]
